| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $94.3M | +46.1% |
| SG&A Expense | $31.7M | +9.9% |
| Operating Income | -$126.0M | -34.9% |
| Net Income | -$117.9M | -28.0% |
| EPS (Basic) | -$1.75 | +24.9% |
| EPS (Diluted) | -$1.75 | +24.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.4M | -45.7% |
| Short-term Investments | $105.8M | -38.7% |
| Current Assets | $140.8M | -40.6% |
| Total Assets | $198.1M | -33.8% |
| Current Liabilities | $15.6M | +18.7% |
| Total Liabilities | $47.4M | -2.8% |
| Stockholders' Equity | $150.7M | -39.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.3M | -17.8% |
| Capital Expenditures | $1.1M | -87.4% |
| Investing Cash Flow | $71.0M | +175.5% |
| Financing Cash Flow | $2.9M | -97.5% |
| Free Cash Flow | -$101.4M | -8.3% |